Paradigm-Shifters: Phosphorylated Prolactin and Short Prolactin Receptors

Journal of Mammary Gland Biology and Neoplasia

Volumn 13, Issue 1, 2008, Pages 69-79

  Huang, KuangTzu ^a   Ueda, Eric ^a   Chen, YenHao ^a   Walker, Ameae M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell junction; Differentiation; Extracellular matrix; Phosphorylated prolactin; S179D prolactin; Short prolactin receptors

Indexed keywords

BETA CASEIN; CASEIN; CYCLIN D1; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; EPITHELIUM CELL; ESTRUS CYCLE; HUMAN; LACTATION; MAMMARY GLAND; NONHUMAN; PREGNANCY; PROLACTIN PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

EID: 40249098552     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-008-9072-x     Document Type: Article

References (88)

1. 1. MY Lorenson AM Walker 2001 Structure-function relationships in prolactin ND Horseman Prolactin Kluwer Academic Publishers Massachusetts 189 217 Lorenson MY, Walker AM. Structure-function relationships in prolactin. Prolactin. Massachusetts: Kluwer Academic Publishers; 2001. p. 189–217.
2. 2. WS Oetting PT Tuazon JA Traugh AM Walker 1986 Phosphorylation of prolactin J Biol Chem 261 1649 1652 3003080 1:CAS:528:DyaL28Xht1ehtbc%3D Oetting WS, Tuazon PT, Traugh JA, Walker AM. Phosphorylation of prolactin. J Biol Chem 1986;261:1649–52.
3. 3. CL Brooks BG Kim P Aphale BE Kleeman GC Johnson 1990 Phosphorylated variant of bovine prolactin Mol Cell Endocrino. 71 117 123 10.1016/0303-7207(90)90248-7 1:CAS:528:DyaK3cXkslWns7c%3D Brooks CL, Kim BG, Aphale P, Kleeman BE, Johnson GC. Phosphorylated variant of bovine prolactin. Mol Cell Endocrino. 1990;71:117–23.
4. 4. C Aramburo JL Montiel JA Proudman LR Berghman CG Scanes 1992 Phosphorylation of PRL and growth hormone J Mol Endocrinol 8 183 191 1632894 1:CAS:528:DyaK38Xks1egs7Y%3D 10.1677/jme.0.0080183 Aramburo C, Montiel JL, Proudman JA, Berghman LR, Scanes CG. Phosphorylation of PRL and growth hormone. J Mol Endocrinol 1992;8:183–91.
5. 5. PT Tuazon MY Lorenson AM Walker JA Traugh 2002 p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin FEBS Lett 515 84 88 11943200 10.1016/S0014-5793(02)02444-4 1:CAS:528:DC%2BD38Xis1eisr8%3D Tuazon PT, Lorenson MY, Walker AM, Traugh JA. p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin. FEBS Lett 2002;515:84–8.
6. 6. W Wu D Coss MY Lorenson CB Kuo X Xu AM Walker 2003 Different Biological Effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways Biochemistry 42 7561 7570 12809512 10.1021/bi034217s 1:CAS:528:DC%2BD3sXktFymtbs%3D Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different Biological Effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 2003;42:7561–70.
7. 7. K Horiguchi S Fukuta M Yoshida T Kosugi JI Naito M Ishida T Haragya 2007 Estrogen regulates the serum level of phosphorylated prolactin in mice J Reprod Dev 53 915 922 17558189 10.1262/jrd.18158 1:CAS:528:DC%2BD2sXhtFGgsL3M Horiguchi K, Fukuta S, Yoshida M, Kosugi T, Naito JI, Ishida M, Haragya T. Estrogen regulates the serum level of phosphorylated prolactin in mice. J Reprod Dev 2007;53:915–22.
8. 8. Y-F Wang J-W Liu M Mamidi AM Walker 1996 Identification of the major site of rat prolactin phosphorylation as serine 177 J Biol Chem 271 2462 2469 8576208 10.1074/jbc.271.5.2462 1:CAS:528:DyaK28XptVKmuw%3D%3D Wang Y-F, Liu J-W, Mamidi M, Walker AM. Identification of the major site of rat prolactin phosphorylation as serine 177. J Biol Chem 1996;271:2462–9.
9. 9. JS Duncan MC Wilkinson RD Burgoyne 2000 Purification of Golgi casein kinase from bovine milk Biochem J 350 463 468 10947960 10.1042/0264-6021:3500463 1:CAS:528:DC%2BD2cXlt1Shurg%3D Duncan JS, Wilkinson MC, Burgoyne RD. Purification of Golgi casein kinase from bovine milk. Biochem J 2000;350:463–8.
10. 10. Y Wang WH Telfer 2000 Cyclic nucleotide-dependent protein phosphorylation in vitellogenic follicles of Hyalophora cecropia Insect Biochem Mol Biol 30 29 34 10646968 10.1016/S0965-1748(99)00094-6 Wang Y, Telfer WH. Cyclic nucleotide-dependent protein phosphorylation in vitellogenic follicles of Hyalophora cecropia. Insect Biochem Mol Biol 2000;30:29–34.
11. 11. LT May PB Sehgal 1992 Phosphorylation of interleukin-6 at serine 54: an early event in the secretory pathway in human fibroblasts Biochem Biphys Res Commun 185 524 530 10.1016/0006-291X(92)91656-B 1:CAS:528:DyaK38Xks1yhs70%3D May LT, Sehgal PB. Phosphorylation of interleukin-6 at serine 54: an early event in the secretory pathway in human fibroblasts. Biochem Biphys Res Commun 1992;185:524–30.
12. 12. Y Goumon JM Strub M Moniatte G Nullans L Poteur P Hubert A Dorsselaer Van D Aunis MH Metz-Boutigue 1996 The C-terminal biphosphorylated proenkephalin-A-(209–237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity Eur J Biochem 235 516 525 8654396 10.1111/j.1432-1033.1996.t01-1-00516.x 1:CAS:528:DyaK28XhtlSjsrg%3D Goumon Y, Strub JM, Moniatte M, Nullans G, Poteur L, Hubert P, Van Dorsselaer A, Aunis D, Metz-Boutigue MH. The C-terminal biphosphorylated proenkephalin-A-(209–237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem 1996;235:516–25.
13. 13. JM Strub Y Goumon K Lugardon C Capon M Lopez M Moniatte AV Dorsselaer D Aunis MH Metz-Boutigue 1996 Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules J Biol Chem 271 28533 28540 8910482 10.1074/jbc.271.45.28533 1:CAS:528:DyaK28XmvVensrY%3D Strub JM, Goumon Y, Lugardon K, Capon C, Lopez M, Moniatte M, Dorsselaer AV, Aunis D, Metz-Boutigue MH. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J Biol Chem 1996;271:28533–40.
14. 14. SS Sooryanarayana PR Adiga SS Visweswariah 1998 Identification and characterization of receptors for riboflavin carrier protein in the chick oocyte. Role of the phosphopeptide in mediating receptor interaction Biochim Biophys Acta 1382 230 242 9540794 1:CAS:528:DyaK1cXhtlOju70%3D Sooryanarayana SS, Adiga PR, Visweswariah SS. Identification and characterization of receptors for riboflavin carrier protein in the chick oocyte. Role of the phosphopeptide in mediating receptor interaction. Biochim Biophys Acta 1998;1382:230–42.
15. 15. AD Nisbet RH Saundry AJ Moir LA Fothergill JE Fothergill 1981 The complete amino acid sequence of hen ovalbumin Eur J Biochem 115 335 345 7016535 10.1111/j.1432-1033.1981.tb05243.x 1:CAS:528:DyaL3MXhs12ktL4%3D Nisbet AD, Saundry RH, Moir AJ, Fothergill LA, Fothergill JE. The complete amino acid sequence of hen ovalbumin. Eur J Biochem 1981;115:335–45.
16. 16. L Crzymala A Castle JC Cheung A Bennick 2000 Cellular phosphorylation of an acidic praline-rich protein, PRP1, a secreted salivary phosphoproteins Biochemistry 39 2023 2031 10.1021/bi9924213 1:CAS:528:DC%2BD3cXms1Whtw%3D%3D Crzymala L, Castle A, Cheung JC, Bennick A. Cellular phosphorylation of an acidic praline-rich protein, PRP1, a secreted salivary phosphoproteins. Biochemistry 2000;39:2023–31.
17. 17. DA Pampena KA Robertson O Litvinova G Lajoie HA Goldberg GK Hunter 2003 Inhibition of hydroxyapatite formation by osteopontin phosphopeptides Biochem J 378 1083 1087 10.1042/BJ20031150 Pampena DA, Robertson KA, Litvinova O, Lajoie G, Goldberg HA, Hunter GK. Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J 2003;378:1083–7.
18. 18. McMahon HE, Sharma S, Shimasaki S. Phosphorylation of BMP-15 and GDF-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology 2008; doi 10.1210/en.2007-1439.
19. 19. Y-F Wang AM Walker 1993 Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between non-phosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation Endocrinology 133 2156 2160 8404666 10.1210/en.133.5.2156 1:CAS:528:DyaK2cXitlyrsA%3D%3D Wang Y-F, Walker AM. Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between non-phosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 1993;133:2156–60.
20. 20. JB Kline H Roehrs CV Clevenger 1999 Functional characterization of the intermediate isoform of the human prolactin receptor J Biol Chem 274 35461 35468 10585417 10.1074/jbc.274.50.35461 1:CAS:528:DyaK1MXotVGnsr8%3D Kline JB, Roehrs H, Clevenger CV. Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 1999;274:35461–8.
21. 21. ZZ Hu J Meng ML Dufau 2001 Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11 Proc Natl Acad Sci USA 276 41086 41094 1:CAS:528:DC%2BD3MXosVKgsLg%3D Hu ZZ, Meng J, Dufau ML. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. Proc Natl Acad Sci USA 2001;276:41086–94.
22. 22. JF Trott RC Hovey S Koduri BK Vonderhaar 2003 Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein J Mol Endocrinol 30 31 47 12580759 10.1677/jme.0.0300031 1:CAS:528:DC%2BD3sXitFWnu70%3D Trott JF, Hovey RC, Koduri S, Vonderhaar BK. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol 2003;30:31–47.
23. 23. SJ Tzeng DI Linzer 1997 Prolactin receptor expression in the developing mouse embryo Mol Reprod Dev 48 45 52 9266760 10.1002/(SICI)1098-2795(199709)48:1<45::AID-MRD6>3.0.CO;2-P 1:CAS:528:DyaK2sXlt1Sis74%3D Tzeng SJ, Linzer DI. Prolactin receptor expression in the developing mouse embryo. Mol Reprod Dev 1997;48:45–52.
24. 24. HN Jabbour PA Kelly 1997 Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function Rev Reprod 2 14 18 9414461 10.1530/ror.0.0020014 1:CAS:528:DyaK2sXhs1Knsb4%3D Jabbour HN, Kelly PA. Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function. Rev Reprod 1997;2:14–8.
25. 25. JJ Berlanga JP Garcia-Ruiz M Perrot-Applanat PA Kelly M Edery 1997 The short form of the prolactin (PRL) receptor silences PRL induction of the β-casein gene promoter Mol Endocrinol 11 1449 1457 9280060 10.1210/me.11.10.1449 1:STN:280:DyaK2svisVWgug%3D%3D Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M. The short form of the prolactin (PRL) receptor silences PRL induction of the β-casein gene promoter. Mol Endocrinol 1997;11:1449–57.
26. 26. BC Hummel GM Brown P Hwang HG Friesen 1974 Human and monkey PRL and growth hormone: separation of polymorphic forms by isoelectric focusing Endocrinology 97 855 867 Hummel BC, Brown GM, Hwang P, Friesen HG. Human and monkey PRL and growth hormone: separation of polymorphic forms by isoelectric focusing. Endocrinology 1974;97:855–67.
27. 27. F Nyberg P Roos L Wide 1980 Human pituitary prolactin: isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities Biochim Biphys Acta 625 255 265 1:CAS:528:DyaL3cXmtlChtLY%3D Nyberg F, Roos P, Wide L. Human pituitary prolactin: isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities. Biochim Biphys Acta 1980;625:255–65.
28. 28. F Nyberg P Roos L Wide 1982 Isolation of rat prolactin isohormones differing in charge, size, and specific immunological activity Prep Biochem 12 153 173 7122424 10.1080/00327488208065559 1:CAS:528:DyaL38XltVCgsb8%3D Nyberg F, Roos P, Wide L. Isolation of rat prolactin isohormones differing in charge, size, and specific immunological activity. Prep Biochem 1982;12:153–73.
29. 29. H Asawaroengchai CS Nicoll 1977 Relationship among bioassay, radioimmunoassay and disc electrophoretic assay methods of measuring rat PRL in pituitary tissue and incubation J Endocrinol 73 301 308 864371 1:CAS:528:DyaE2sXkvVSku7k%3D Asawaroengchai H, Nicoll CS. Relationship among bioassay, radioimmunoassay and disc electrophoretic assay methods of measuring rat PRL in pituitary tissue and incubation. J Endocrinol 1977;73:301–8.
30. 30. H Asawaroengchai SM Russel CS Nicoll 1978 Electrophoretically separable forms of rat PRL with different bioassay and radioimmunoassay activities Endocrinology 102 407 414 743965 1:CAS:528:DyaE1cXhsVOks74%3D Asawaroengchai H, Russel SM, Nicoll CS. Electrophoretically separable forms of rat PRL with different bioassay and radioimmunoassay activities. Endocrinology 1978;102:407–14.
31. 31. YN Sinha SR Baxter 1979 Identification of a non-immunoreactive but highly bioactive form of PRL in the mouse pituitary by gel electrophoresis Biochem Biophys Res Commun 86 325 330 106851 10.1016/0006-291X(79)90869-6 1:CAS:528:DyaE1MXhtFylsbY%3D Sinha YN, Baxter SR. Identification of a non-immunoreactive but highly bioactive form of PRL in the mouse pituitary by gel electrophoresis. Biochem Biophys Res Commun 1979;86:325–30.
32. 32. DI Lebovic CS Nicoll 1992 Measurement of inducible proteins improves the precision of the local pigeon crop-sac bioassay for prolactin Life Sci 50 2019 2024 1593930 10.1016/0024-3205(92)90532-T 1:CAS:528:DyaK38XktVWju7o%3D Lebovic DI, Nicoll CS. Measurement of inducible proteins improves the precision of the local pigeon crop-sac bioassay for prolactin. Life Sci 1992;50:2019–24.
33. 33. P Hwang H Guyda H Friesen 1972 Purification of human prolactin J Biol Chem 247 1955 1958 4622740 1:CAS:528:DyaE38Xht1eks74%3D Hwang P, Guyda H, Friesen H. Purification of human prolactin. J Biol Chem 1972;247:1955–8.
34. 34. P Hwang M Robertson H Guyda H Friesen 1973 Purification of human PRL from frozen pituitary glands J Clin Endocrinol Metab 36 1110 1118 4706200 1:CAS:528:DyaE3sXksFSmu70%3D Hwang P, Robertson M, Guyda H, Friesen H. Purification of human PRL from frozen pituitary glands. J Clin Endocrinol Metab 1973;36:1110–8.
35. 35. P Hwang JB Murray JW Jacobs HD Niall H Friesen 1974 Human amniotic fluid prolactin: purification by affinity chromatography and amino-terminal sequence Biochemistry 13 2354 2358 4857569 10.1021/bi00708a018 1:CAS:528:DyaE2cXkslelu7w%3D Hwang P, Murray JB, Jacobs JW, Niall HD, Friesen H. Human amniotic fluid prolactin: purification by affinity chromatography and amino-terminal sequence. Biochemistry 1974;13:2354–8.
36. 36. UJ Lewis EV Cheever WC Hopkins 1970 Kinetic study of the deamidation of growth hormone and prolactin Biochim Biophys Acta 214 498 508 5534305 1:CAS:528:DyaE3cXlt1Ontr8%3D Lewis UJ, Cheever EV, Hopkins WC. Kinetic study of the deamidation of growth hormone and prolactin. Biochim Biophys Acta 1970;214:498–508.
37. 37. AB Robinson JH McKerrow P Cary 1970 Controlled deamidation of peptides and proteins: an experimental hazard and a possible biological timer Proc Natl Acad Sci USA 66 753 757 5269237 10.1073/pnas.66.3.753 1:CAS:528:DyaE3cXkvFCksbg%3D Robinson AB, McKerrow JH, Cary P. Controlled deamidation of peptides and proteins: an experimental hazard and a possible biological timer. Proc Natl Acad Sci USA 1970;66:753–7.
38. 38. LS Haro FJ Talamantes 1985 Secreted mouse PRL and stored ovine prolactin. I. Biochemical characterization, isolation, and purification of their electrophoretic isoforms Endocrinology 116 346 352 3964749 1:CAS:528:DyaL2MXls1ejtA%3D%3D Haro LS, Talamantes FJ. Secreted mouse PRL and stored ovine prolactin. I. Biochemical characterization, isolation, and purification of their electrophoretic isoforms. Endocrinology 1985;116:346–52.
39. 39. LS Haro FJ Talamantes 1985 Secreted mouse PRL and stored ovine PRL II: role of amides in receptor binding and immunoreactivity Endocrinology 116 353 358 2981070 1:CAS:528:DyaL2MXls1artA%3D%3D Haro LS, Talamantes FJ. Secreted mouse PRL and stored ovine PRL II: role of amides in receptor binding and immunoreactivity. Endocrinology 1985;116:353–8.
40. 40. JR Greenan E Balden TWC Ho AM Walker 1989 Biosynthesis of the secreted 24 kd isoforms of prolactin Endocrinology 125 2041 2048 2791977 1:CAS:528:DyaL1MXlvVOksLw%3D Greenan JR, Balden E, Ho TWC, Walker AM. Biosynthesis of the secreted 24 kd isoforms of prolactin. Endocrinology 1989;125:2041–8.
41. 41. BG Kim CL Brooks 1993 Isolation and characterization of phosphorylated bovine prolactin Biochem J 296 41 47 8250856 1:CAS:528:DyaK2cXntlE%3D Kim BG, Brooks CL. Isolation and characterization of phosphorylated bovine prolactin. Biochem J 1993;296:41–7.
42. 42. TWC Ho F-S Leong CH Olaso AM Walker 1993 Secretion of specific non-phosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle Neuroendocrinology 58 160 165 8264862 1:CAS:528:DyaK3sXms1aqsrw%3D Ho TWC, Leong F-S, Olaso CH, Walker AM. Secretion of specific non-phosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle. Neuroendocrinology 1993;58:160–5.
43. 43. TWC Ho M Kawaminami AM Walker 1993 Secretion of phosphorylated and non-phosphorylated monomer prolactin isoforms during rat pregnancy and pseudopregnancy Endocrine 1 435 439 Ho TWC, Kawaminami M, Walker AM. Secretion of phosphorylated and non-phosphorylated monomer prolactin isoforms during rat pregnancy and pseudopregnancy. Endocrine 1993;1:435–9.
44. 44. TE Johnson M Vue S Brekhus A Khong TWC Ho AM Walker 2003 Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats Endocrine 20 101 110 12668874 10.1385/ENDO:20:1-2:101 1:CAS:528:DC%2BD3sXjtFyks7w%3D Johnson TE, Vue M, Brekhus S, Khong A, Ho TWC, Walker AM. Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats. Endocrine 2003;20:101–10.
45. 45. VL Williams A DeGuzman H Dang M Kawaminami TWC Ho DG Carter AM Walker 2007 Common and specific effects of the two major forms of prolactin (PRL) in the rat testis Am J Physiol 293 E1795 E1803 10.1152/ajpcell.00553.2006 1:CAS:528:DC%2BD2sXht1WltbrM Williams VL, DeGuzman A, Dang H, Kawaminami M, Ho TWC, Carter DG, Walker AM. Common and specific effects of the two major forms of prolactin (PRL) in the rat testis. Am J Physiol 2007;293:E1795–803.
46. 46. TJ Chen C-YB Kuo KF Tsai J-W Liu D-Y Chen AM Walker 1998 Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone Endocrinology 139 609 616 9449632 10.1210/en.139.2.609 1:CAS:528:DyaK1cXns1Olsg%3D%3D Chen TJ, Kuo C-YB, Tsai KF, Liu J-W, Chen D-Y, Walker AM. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 1998;139:609–16.
47. 47. W Wu D Coss MY Lorenson CB Kuo X Xu AM Walker 2003 Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways Biochemistry 42 7561 7570 12809512 10.1021/bi034217s 1:CAS:528:DC%2BD3sXktFymtbs%3D Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry 2003;42:7561–70.
48. 48. JR Wicks CL Brooks 1999 Prolactin kinase activity in bovine anterior pituitary sub-cellular fractions Mol Cell Endocrinol 147 125 132 10195699 10.1016/S0303-7207(98)00210-X 1:CAS:528:DyaK1MXivVGksA%3D%3D Wicks JR, Brooks CL. Prolactin kinase activity in bovine anterior pituitary sub-cellular fractions. Mol Cell Endocrinol 1999;147:125–32.
49. 49. Liu JW, Walker AM. Long term effect of estradiol and thyrotropin releasing hormone on the release of non-phosphorylated and phosphorylated monomer prolactin in vitro. Abstract 1363, 76th Annual meeting of the Endocrine Soc, Anaheim, CA 1994.
50. 50. MJ Naylor SR Oakes M Gardiner-Garden J Harris K Blazek TWC Ho FC Li D Wynick AM Walker CJ Ormandy 2005 Transcriptional changes underlying the secretory activation phase of mammary gland development Mol Endocrinol 19 1868 1883 15705664 10.1210/me.2004-0254 1:CAS:528:DC%2BD2MXlvFSku78%3D Naylor MJ, Oakes SR, Gardiner-Garden M, Harris J, Blazek K, Ho TWC, Li FC, Wynick D, Walker AM, Ormandy CJ. Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol Endocrinol 2005;19:1868–83.
51. 51. D Wynick A Bacon 2002 Targeted disruption of galanin: insights from knock-out studies Neuropeptides 36 132 144 12359504 10.1054/npep.2002.0888 1:CAS:528:DC%2BD38XnsFGktbw%3D Wynick D, Bacon A. Targeted disruption of galanin: insights from knock-out studies. Neuropeptides 2002;36:132–44.
52. 52. K Horiguchi S Fukuta M Yoshida T Kosugi J Naito M Ishida T Harigaya 2007 Estrogen regulates the serum level of phosphorylated prolactin in mice J Reprod Dev. 53 915 922 17558189 10.1262/jrd.18158 1:CAS:528:DC%2BD2sXhtFGgsL3M Horiguchi K, Fukuta S, Yoshida M, Kosugi T, Naito J, Ishida M, Harigaya T. Estrogen regulates the serum level of phosphorylated prolactin in mice. J Reprod Dev. 2007;53:915–22.
53. 53. CE Grosvenor MF Picciano CR Baumrucker 1993 Hormones and growth factors in milk Endocr Rev 14 710 728 8119234 10.1210/er.14.6.710 1:CAS:528:DyaK2cXnsFOhtA%3D%3D Grosvenor CE, Picciano MF, Baumrucker CR. Hormones and growth factors in milk. Endocr Rev 1993;14:710–28.
54. 54. LA Ellis MF Picciano 1995 Bioactive and immunoreactive prolactin variants in human milk Endocrinology 136 2711 2720 7750496 10.1210/en.136.6.2711 1:CAS:528:DyaK2MXlslGguro%3D Ellis LA, Picciano MF. Bioactive and immunoreactive prolactin variants in human milk. Endocrinology 1995;136:2711–20.
55. 55. SW Shry WR Crowley CE Grosvenor 1986 Effect of neonatal prolactin deficiency on prepubertal tuberoinfundibular and tuberohypophyseal dopaminergic neuronal activity Endocrinology 119 1217 1221 10.1210/endo-119-3-1217 Shry SW, Crowley WR, Grosvenor CE. Effect of neonatal prolactin deficiency on prepubertal tuberoinfundibular and tuberohypophyseal dopaminergic neuronal activity. Endocrinology 1986;119:1217–21.
56. 56. M Olivier-Bousquet 1998 Transferrin and prolactin transcytosis in the lactating mammary epithelial cell J Mammary Gland Biol Neoplasia 3 303 313 10.1023/A:1018767528017 Olivier-Bousquet M. Transferrin and prolactin transcytosis in the lactating mammary epithelial cell. J Mammary Gland Biol Neoplasia 1998;3:303–13.
57. 57. KA Krown YF Wang TWC Ho PA Kelly AM Walker 1992 Prolactin isoform 2 as an autocrine growth factor for GH 3 cells Endocrinology 131 595 602 1639009 10.1210/en.131.2.595 1:CAS:528:DyaK38XlsVertb4%3D Krown KA, Wang YF, Ho TWC, Kelly PA, Walker AM. Prolactin isoform 2 as an autocrine growth factor for GH 3 cells. Endocrinology 1992;131:595–602.
58. 58. KA Krown YF Wang AM Walker 1994 Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line Endocrinology 134 1546 1552 8119197 10.1210/en.134.3.1546 1:CAS:528:DyaK2cXitVyqt70%3D Krown KA, Wang YF, Walker AM. Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology 1994;134:1546–52.
59. 59. M Wittekind J Reizer J Deutscher MH Saier RE Klevit 1989 Common structural changes accompany the functional activation of HPr by seryl phosphorylation or by serine to aspartate substitution Biochemistry 28 9908 9912 2515891 10.1021/bi00452a005 1:CAS:528:DyaK3cXivFGg Wittekind M, Reizer J, Deutscher J, Saier MH, Klevit RE. Common structural changes accompany the functional activation of HPr by seryl phosphorylation or by serine to aspartate substitution. Biochemistry 1989;28:9908–12.
60. 60. S Bernichtein S Kinet S Jeay M Llovera D Madern PA Kelly V Goffin 2001 S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist Endocrinology. 142 3950 3963 11517174 10.1210/en.142.9.3950 1:CAS:528:DC%2BD3MXmsFSgsL4%3D Bernichtein S, Kinet S, Jeay S, Llovera M, Madern D, Kelly PA, Goffin V. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist. Endocrinology. 2001;142:3950–63.
61. 61. CRJ Soares A Glezer K Okazaki EKM Ueda SR Heller AM Walker V Goffin P Bartolini 2006 Physico-chemical and biological characterizations of two human prolactin analogs exhibiting controversial bioactivity, synthesized in Chinese hamster ovary (CHO) cells Protein Expr Purif 48 182 194 16814566 1:CAS:528:DC%2BD28XntlWjt7s%3D Soares CRJ, Glezer A, Okazaki K, Ueda EKM, Heller SR, Walker AM, Goffin V, Bartolini P. Physico-chemical and biological characterizations of two human prolactin analogs exhibiting controversial bioactivity, synthesized in Chinese hamster ovary (CHO) cells. Protein Expr Purif 2006;48:182–94.
62. 62. MD Schroeder JL Brockman AM Walker LA Schuler 2003 Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D PRL Endocrinology 144 5300 5307 12970160 10.1210/en.2003-0826 1:CAS:528:DC%2BD3sXpsV2gtbg%3D Schroeder MD, Brockman JL, Walker AM, Schuler LA. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D PRL. Endocrinology 2003;144:5300–7.
63. 63. R Bridges B Rigero E Byrnes L Yang AM Walker 2001 Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed nulliparous female rats Endocrinology 142 730 739 11159845 10.1210/en.142.2.730 1:CAS:528:DC%2BD3MXhtFSrtrs%3D Bridges R, Rigero B, Byrnes E, Yang L, Walker AM. Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed nulliparous female rats. Endocrinology 2001;142:730–9.
64. 64. CB Kuo W Wu X Xu L Yang C Chen D Coss B Birdsall D Nasseri AM Walker 2002 Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland Cell Tissue Res 309 429 437 12195299 10.1007/s00441-002-0598-8 1:CAS:528:DC%2BD38XmsVChu78%3D Kuo CB, Wu W, Xu X, Yang L, Chen C, Coss D, Birdsall B, Nasseri D, Walker AM. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland. Cell Tissue Res 2002;309:429–37.
65. 65. CJ Ormandy A Camus J Barra D Damotte B Lucas H Buteau M Edery N Brousse C Babinet N Binart PA Kelly 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse Genes Dev 11 167 178 9009200 10.1101/gad.11.2.167 1:CAS:528:DyaK2sXpsVKmsg%3D%3D Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997;11:167–78.
66. 66. RC Hovey JF Trott E Ginsburg A Goldhar MM Sasaki SJ Fountain K Sundararajan BK Vonderhaar 2001 Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland Dev Dyn 222 192 205 11668597 10.1002/dvdy.1179 1:CAS:528:DC%2BD3MXot1Klt70%3D Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 2001;222:192–205.
67. 67. E Ueda U Ozerdem YH Chen M Yao KT Huang H Sun M Martins-Green P Bartolini AM Walker 2006 A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone Endocr Relat Cancer 13 95 111 16601282 10.1677/erc.1.01076 1:CAS:528:DC%2BD28XltlKkurw%3D Ueda E, Ozerdem U, Chen YH, Yao M, Huang KT, Sun H, Martins-Green M, Bartolini P, Walker AM. A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocr Relat Cancer 2006;13:95–111.
68. 68. E Ueda H-L Lo P Bartolini AM Walker 2006 S179D prolactin (PRL) primarily uses the extrinsic pathway and MAPkinase signaling to induce apoptosis in human endothelial cells Endocrinology 147 4627 4637 16840547 10.1210/en.2006-0348 1:CAS:528:DC%2BD28XhtVSksb3P Ueda E, Lo H-L, Bartolini P, Walker AM. S179D prolactin (PRL) primarily uses the extrinsic pathway and MAPkinase signaling to induce apoptosis in human endothelial cells. Endocrinology 2006;147:4627–37.
69. 69. I Struman F Bentzien H Lee V Mainfroid G D’Angelo V Goffin RI Weiner JA Martial 1999 Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis Proc Natl Acad Sci USA. 96 1246 1251 9990009 10.1073/pnas.96.4.1246 1:CAS:528:DyaK1MXhsFSrt7s%3D Struman I, Bentzien F, Lee H, Mainfroid V, D’Angelo G, Goffin V, Weiner RI, Martial JA. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA. 1999;96:1246–51.
70. 70. S Bernichtein S Jeay R Vaudry PA Kelly V Goffin 2003 New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity Endocrine 20 177 189 12668884 10.1385/ENDO:20:1-2:177 1:CAS:528:DC%2BD3sXjtFyksLw%3D Bernichtein S, Jeay S, Vaudry R, Kelly PA, Goffin V. New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity. Endocrine 2003;20:177–89.
71. 71. MM Krishna Y Lin SW Englander 2004 Protein misfolding: optional barriers, misfolded intermediates, and pathway heterogeneity J Mol Biol. 343 1095 1109 15476824 10.1016/j.jmb.2004.08.098 1:CAS:528:DC%2BD2cXotlClu78%3D Krishna MM, Lin Y, Englander SW. Protein misfolding: optional barriers, misfolded intermediates, and pathway heterogeneity. J Mol Biol. 2004;343:1095–109.
72. 72. J Mershon W Sall N Mitchner N Ben-Jonathan 1995 Prolactin is a local growth factor in rat mammary tumors Endocrinology 136 3619 3623 7628401 10.1210/en.136.8.3619 1:CAS:528:DyaK2MXntFKntb0%3D Mershon J, Sall W, Mitchner N, Ben-Jonathan N. Prolactin is a local growth factor in rat mammary tumors. Endocrinology 1995;136:3619–23.
73. 73. NY Chen L Holle W Li SK Peirce MT Beck WY Chen 2002 In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R Int J Oncol 20 813 818 11894130 1:CAS:528:DC%2BD38XislOqsrg%3D Chen NY, Holle L, Li W, Peirce SK, Beck MT, Chen WY. In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. Int J Oncol 2002;20:813–8.
74. 74. V Goffin S Bernichtein P Touraine PA Kelly 2005 Development and potential clinical uses of human prolactin receptor antagonists Endocr Rev 26 400 422 15814850 10.1210/er.2004-0016 1:CAS:528:DC%2BD2MXltVWru7k%3D Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 2005;26:400–22.
75. 75. W Wu YH Chen E Ueda D Tan P Bartolini AM Walker 2006 Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells Oncol Res 16 75 84 16898268 1:CAS:528:DC%2BD28XntFaktLw%3D Wu W, Chen YH, Ueda E, Tan D, Bartolini P, Walker AM. Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells. Oncol Res 2006;16:75–84.
76. 76. GM Zinser J Welsh 2004 Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice Mol Endocrinol 18 2208 2223 15178742 10.1210/me.2003-0469 1:CAS:528:DC%2BD2cXnsVKgtLg%3D Zinser GM, Welsh J. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol 2004;18:2208–23.
77. 77. D Tan DA Johnson W Wu L Zeng YH Chen WY Chen BK Vonderhaar AM Walker 2005 Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo-and hetero-pairs of long and short PRL receptors in living human cells Mol Endocrinol 19 1291 1303 15695371 10.1210/me.2004-0304 1:CAS:528:DC%2BD2MXktFentrc%3D Tan D, Johnson DA, Wu W, Zeng L, Chen YH, Chen WY, Vonderhaar BK, Walker AM. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo-and hetero-pairs of long and short PRL receptors in living human cells. Mol Endocrinol 2005;19:1291–303.
78. 78. WP Chang CV Clevenger 1996 Modulation of growth factor receptor function by isoform heterodimerization Proc Natl Acad Sci U S A 93 5947 5952 8650199 10.1073/pnas.93.12.5947 1:CAS:528:DyaK28Xjs1OjsL0%3D Chang WP, Clevenger CV. Modulation of growth factor receptor function by isoform heterodimerization. Proc Natl Acad Sci U S A 1996;93:5947–52.
79. 79. W Wu E Ginsburg BK Vonderhaar AM Walker 2005 S179D prolactin increases vitamin D receptor and p21 through upregulation of short 1b prolactin receptor in human prostate cancer cells Cancer Res 65 7509 7515 16103106 10.1158/0008-5472.CAN-04-3350 1:CAS:528:DC%2BD2MXns1Wqs7s%3D Wu W, Ginsburg E, Vonderhaar BK, Walker AM. S179D prolactin increases vitamin D receptor and p21 through upregulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Res 2005;65:7509–15.
80. 80. F Cerignoli S Rahmouni Z Ronai T Mustelin 2006 Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation Cell cycle 5 2210 2215 17012840 1:CAS:528:DC%2BD2sXjsVymsw%3D%3D Cerignoli F, Rahmouni S, Ronai Z, Mustelin T. Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation. Cell cycle 2006;5:2210–5.
81. 81. D Tan KT Huang E Ueda AM Walker 2007 S2 deletion variants of human prolactin receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain Biochemistry 47 479 489 18081308 10.1021/bi7013882 1:CAS:528:DC%2BD2sXhsVehu73N Tan D, Huang KT, Ueda E, Walker AM. S2 deletion variants of human prolactin receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain. Biochemistry 2007;47:479–89.
82. 82. N Binart P Imbert-Bollore N Baran C Vigliaetta PA Kelly 2003 A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice Mol Endocrinol 17 1066 1074 12624115 10.1210/me.2002-0181 1:CAS:528:DC%2BD3sXktlymtr4%3D Binart N, Imbert-Bollore P, Baran N, Vigliaetta C, Kelly PA. A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol 2003;17:1066–74.
83. 83. CD Roskelley PY Desprez MJ Bissell 1994 Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction Proc Natl Acad Sci U S A. 91 12378 12382 7528920 10.1073/pnas.91.26.12378 1:STN:280:DyaK2M7gsl2lsg%3D%3D Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A. 1994;91:12378–82.
84. 84. R Xu VA Spencer MJ Bissell 2007 Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors J Biol Chem 282 14992 14999 17387179 10.1074/jbc.M610316200 1:CAS:528:DC%2BD2sXltFemu7g%3D Xu R, Spencer VA, Bissell MJ. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors. J Biol Chem 2007;282:14992–9.
85. 85. I Gourdou L Gabou J Paly AY A Kermabon L Belair J Djiane 1996 Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family Mol Endocrinol 10 45 56 8838144 10.1210/me.10.1.45 1:CAS:528:DyaK28XjslOksQ%3D%3D Gourdou I, Gabou L, Paly J, A Kermabon AY, Belair L, Djiane J. Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. Mol Endocrinol 1996;10:45–56.
86. 86. RC Lee JA Walters ME Reyland SM Anderson 1999 Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules J Biol Chem 274 10024 10034 10187780 10.1074/jbc.274.15.10024 1:CAS:528:DyaK1MXis1GjsbY%3D Lee RC, Walters JA, Reyland ME, Anderson SM. Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules. J Biol Chem 1999;274:10024–34.
87. 87. J Meng CH Tsai-Morris ML Dufau 2004 Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma Cancer Res 64 5677 5682 15313907 10.1158/0008-5472.CAN-04-1019 1:CAS:528:DC%2BD2cXmslalu7w%3D Meng J, Tsai-Morris CH, Dufau ML. Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma. Cancer Res 2004;64:5677–82.
88. 88. AM Walker 2007 S179D prolactin: antagonistic agony Mol Cell Endocrinol 276 1 9 17669587 10.1016/j.mce.2007.06.001 1:CAS:528:DC%2BD2sXpvFGks74%3D Walker AM. S179D prolactin: antagonistic agony. Mol Cell Endocrinol 2007;276:1–9.